SEB Asset Management
DFTX icon

SEB Asset Management’s Definium Therapeutics DFTX Stock Holding History

SEB Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.93M Hold
208,254
– – 0.03% 372
2026
Q2 		$9.8M Buy
+208,254
New +$5.15M 0.04% 340

Other funds holding DFTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

SEB Asset Management's DFTX Position: Q3 2026 in Review

SEB Asset Management held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 208,254 shares worth $7.93M. The position accounts for 0.03% of the portfolio, ranked #372.

SEB Asset Management first reported a position in DFTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.8M in Q2 2026. 253 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • SEB Asset Management held 208,254 shares of Definium Therapeutics worth $7.93M as of Q3 2026.
  • SEB Asset Management left its Definium Therapeutics share count unchanged in Q3 2026.
  • Definium Therapeutics made up 0.03% of SEB Asset Management's portfolio in Q3 2026, its #372 holding.
  • SEB Asset Management first reported a position in Definium Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Definium Therapeutics position peaked at $9.8M in Q2 2026.
  • 253 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.